4 results

• ExplainedHow can a medicine change what supermarkets sell?GLP-1 medicines reduce appetite and food intake for many users. At population scale, that can alter portion sizes, snacking frequency and the types of foods companies choose to develop, even though the medicines are not food products themselves.
• MoneyWeight-loss drugs are becoming a snack-company problem.PepsiCo is already fighting inflation, weak snack volumes and investor pressure. GLP-1 drugs add a more structural question: what happens to a food business built around frequent snacking when some customers feel less hungry?
• MoneyInflation can fall. The cost-of-living crisis can keep going.When inflation slows, prices usually do not return to where they started. New IMF research says repeated food and energy shocks can also change what households expect about future inflation and push more people into poverty.
• PeopleUnemployment can be low while the job market still feels terrible.The U.S. is approaching the 2026 midterms with unemployment around levels economists call full employment, yet hiring is slower, job switching is weaker and many workers feel insecure. The unemployment rate only measures one part of labor-market health.